Skip to main content
. 2020 Nov 4;21(21):8270. doi: 10.3390/ijms21218270

Figure 6.

Figure 6

Other systemic soluble factor expression after CD362+ UC-MSC administration. Levels of circulating macrophage colony-stimulator factor (M-CSF) (A), granulocyte-macrophage colony-stimulating factor (GM-CSF) (B), MIP-1α (C) and vascular endothelial growth factor (VEGF) (D) in serum were reduced in the CD362+ UC-MSC treated group compared with vehicle administration. Bars represent mean (n = 3/8/8), error bars represent SD. * Statistically significant (p < 0.05) with respect to vehicle control group.